Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | RAD52 | P43351 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 6/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5067226 | 0.94 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL11184931 | 0.94 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL31011371 | 0.94 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL5497221 | 0.94 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL11184933 | 0.87 | NAAA (0.58) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL5497225 | 0.87 | NAAA (0.58) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL27873320 | 0.86 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL27412964 | 0.86 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL27889668 | 0.86 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL22462401 | 0.86 | NAAA (0.67) | NAAAFAAHEPHX1RAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2866898-B1 | ULTRAVIOLET RADIATION ABSORBING POLYMERS | JOHNSON & JOHNSON CONSUMER INC (US) | 2018-04-04 | — | — | EP | disclosed |
| US-9469725-B2 | Ultraviolet radiation absorbing polymers | JOHNSON & JOHNSON CONSUMER INC. (US) | 2016-10-18 | — | — | US | disclosed |
| EP-2866898-A1 | ULTRAVIOLET RADIATION ABSORBING POLYMERS | Johnson & Johnson Consumer Companies, Inc. (US) | 2015-05-06 | — | — | EP | disclosed |
| WO-2014004176-A1 | ULTRAVIOLET RADIATION ABSORBING POLYMERS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2014-01-03 | — | — | WO | disclosed |
| US-20140004060-A1 | ULTRAVIOLET RADIATION ABSORBING POLYMERS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2014-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140004060-A1 | ULTRAVIOLET RADIATION ABSORBING POLYMERS | PARG, PARN, PUF60 | NAAA 629/4885FAAH 1034/4885EPHX1 2650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.